Oct 30, 2025 21:45
BBOT - BridgeBio Oncology Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 12.18 0.26 (2.09%) | --- | 0.02 (0.12%) | -0.17 (-1.35%) | --- | 0.26 (2.09%) | --- | --- |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 57.69
- VWAP:
- 12.43
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Oct 25, 2025 16:30
Aug 20, 2025 12:00